InVivo Therapeutics Holdings Analysis
| NVIVDelisted Stock | USD 1.38 0.07 5.34% |
InVivo Therapeutics Holdings is overvalued with Real Value of 1.15 and Hype Value of 1.38. The main objective of InVivo Therapeutics delisted stock analysis is to determine its intrinsic value, which is an estimate of what InVivo Therapeutics Holdings is worth, separate from its market price. There are two main types of InVivo Therapeutics' stock analysis: fundamental analysis and technical analysis.
The InVivo Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. InVivo Therapeutics is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. InVivo Stock trading window is adjusted to America/New York timezone.
InVivo |
InVivo Stock Analysis Notes
The company has price-to-book ratio of 0.1. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. InVivo Therapeutics recorded a loss per share of 3.28. The entity last dividend was issued on the 12th of February 2020. The firm had 1:25 split on the 27th of April 2022. InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries . The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. Invivo Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people. To find out more about InVivo Therapeutics Holdings contact Richard MD at 617 863 5500 or learn more at https://www.invivotherapeutics.com.InVivo Therapeutics Investment Alerts
| InVivo Therapeutics is not yet fully synchronised with the market data | |
| InVivo Therapeutics may become a speculative penny stock | |
| InVivo Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (9.33 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| InVivo Therapeutics Holdings currently holds about 13.03 M in cash with (10.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
InVivo Therapeutics Upcoming and Recent Events
| 14th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
InVivo Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 995.92 K.InVivo Therapeutics Outstanding Bonds
InVivo Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. InVivo Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most InVivo bonds can be classified according to their maturity, which is the date when InVivo Therapeutics Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| INVH 415 15 APR 32 Corp BondUS46188BAD47 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| INVH 2 15 AUG 31 Corp BondUS46188BAA08 | View | |
| INVH 23 15 NOV 28 Corp BondUS46188BAB80 | View | |
| INVH 27 15 JAN 34 Corp BondUS46188BAC63 | View |
InVivo Therapeutics Predictive Daily Indicators
InVivo Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of InVivo Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About InVivo Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how InVivo Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling InVivo shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as InVivo Therapeutics. By using and applying InVivo Stock analysis, traders can create a robust methodology for identifying InVivo entry and exit points for their positions.
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries . The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. Invivo Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding InVivo Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in InVivo Stock
If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |